Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2024373662-A1 · Nov 7, 2024 · US
US9359549B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9359549-B2 |
| Application number | US-201013263294-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 6, 2010 |
| Priority date | Apr 6, 2009 |
| Publication date | Jun 7, 2016 |
| Grant date | Jun 7, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds comprising a metal complex having novel ligands are provided. In particular, the compound is an iridium complex comprising novel aza DBX ligands. The compounds may be used in organic light emitting devices, particularly as emitting dopants, providing improved efficiency, low operating voltage, and long lifetime.
Opening claim text (preview).
The invention claimed is: 1. A compound having the structure of formula (L) n (L′) 3-n Ir, wherein n is 1 or 2, ligand L has a structure and ligand L′ has a structure selected from the group consisting of: wherein each A is independently a 5-membered or 6-membered aromatic or heteroaromatic ring; wherein R A is a substituent having the structure wherein R A is fused to the pyridine ring of FORMULA I and the dashed line in R A indicates where R A is fused to the pyridine ring of FORMULA I; wherein each X is independently selected from the group consisting of CRR″, C═O, BR, O, S, and Se; wherein each R and R′ is independently selected from hydrogen and alkyl; wherein each R 1 , R 3 , R 4 , and R 5 may independently represent mono, di, tri, or tetra substitutions; wherein R 2 may represent mono or di substitutions; wherein each of R 1 , R 7 , R 3 , R 4 , and R 5 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylalkyl, aryl, and heteroaryl; and wherein the compound is heteroleptic. 2. The compound of claim 1 , wherein ligand L′ is 3. The compound of claim 2 , wherein the compound is selected from the group consisting of: 4. The compound of claim 1 , wherein X is O. 5. The compound of claim 1 , wherein X is S. 6. The compound of claim 1 , wherein X is CRR′. 7. The compound of claim 1 , wherein X is CO. 8. The compound of claim 1 , wherein the compound is selected from the group consisting of: 9. The compound of claim 8 , wherein the compound is selected from the group consisting of Compound 1-Compound 12. 10. The compound of claim 8 , wherein the compound is selected from the group consisting of Compound 13-Compound 24. 11. The compound of claim 8 , wherein the compound is selected from the group consisting of Compound 37-Compound 48. 12. The compound of claim 8 , wherein the compound is selected from the group consisting of Compound 49-Compound 60. 13. An organic light emitting device, comprising: an anode; a cathode; and an organic layer disposed between the anode and the cathode, the organic layer comprising a compound having the structure of formula (L) n (L′) 3-n Ir, wherein n is 1 or 2, ligand L has a structure and ligand L′ has a structure selected from the group consisting of: wherein each A is independently a 5-membered or 6-membered aromatic or heteroaromatic ring; wherein R A is a substituent having the structure wherein R A is fused to the pyridine ring of FORMULA I and the dashed line in R A indicates where R A is fused to the pyridine ring of FORMULA I; wherein each X is independently selected from the group consisting of CRR′, C═O; BR, O; S, and Se; wherein each R and R′ is independently selected from hydrogen and alkyl; wherein each R 1 , R 3 , R 4 , and R 5 may independently represent mono, di, tri, or tetra substitutions; wherein R 2 may represent mono or di substitutions; wherein each of R 1 , R 2 , R 3 , R 4 , and R 5 are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, arylalkyl, aryl, and heteroaryl; and wherein the compound is heteroleptic. 14. The device of claim 13 , wherein the organic layer is an emissive layer and the compound is an emitting dopant. 15. The device of claim 13 , wherein the organic layer further comprises a host. 16. The device of claim 15 , wherein the host has the formula: wherein R′ 2 and R′ 4 may represent mono, di, or tri substitutions; wherein R′ 1 , R′ 3 , R′ 5 , and R′ 6 may represent mono, di, tri, or tetra substitutions; and wherein each of R′ 1 , R′ 2 , R′ 3 , R′ 4 , R′ 5 , and R′ 6 are each independently selected from the group consisting of hydrogen, alkyl and aryl. 17. The device of claim 13 , wherein the compound is selected from the group consisting of:
containing one nitrogen atom as the heteroatom · CPC title
characterised by the chemical or physical composition or the arrangement of the electroluminescent material {, or by the simultaneous addition of the electroluminescent material in or onto the light source} · CPC title
containing organic luminescent materials · CPC title
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
with oxygen · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.